STRS Ohio’s Astria Therapeutics ATXS Stock Holding History

STRS Ohio’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,400	Closed	-$44.5K	–	2131
2025 Q4	$44.5K	Buy	+3,400	New	+$40.6K	﹤0.01%	2003
2024 Q4	–	Sell	-11,200	Closed	-$123K	–	1895
2024 Q3	$123K	Buy	11,200 +9,900	+762%	+$110K	﹤0.01%	1668
2024 Q2	$11.8K	Hold	1,300	–	–	﹤0.01%	1915
2024 Q1	$18K	Buy	+1,300	New	+$16.2K	﹤0.01%	1858
2016 Q2	–	Sell	-25	Closed	-$7K	–	1917
2016 Q1	$7K	Hold	25	–	–	﹤0.01%	1866
2015 Q4	$11K	Hold	25	–	–	﹤0.01%	1878
2015 Q3	$12K	Buy	+25	New	+$17.9K	﹤0.01%	1844

STRS Ohio's ATXS Position: Q1 2026 in Review

STRS Ohio sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 3,400 shares — an estimated $44.5K sold.

STRS Ohio first reported a position in ATXS in Q3 2015 and held it in 7 quarters. The position peaked at $123K in Q3 2024. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

STRS Ohio reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
STRS Ohio sold 3,400 Astria Therapeutics shares in Q1 2026, an estimated $44.5K.
STRS Ohio first reported a position in Astria Therapeutics in Q3 2015 and held it in 7 quarters.
STRS Ohio's Astria Therapeutics position peaked at $123K in Q3 2024.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.